NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Friday, March 19, 2010 11:43 PM

Dynavax Technologies Corporation

Type: Company

Name: Dynavax Technologies Corporation

First Reported Mar 17 2010 - Updated Mar 17 2010 - 1 Documents

Dynavax aims to submit application for hepatitis B vaccine early

Dynavax Technologies completed enrollment for a Phase III trial of hepatitis B vaccine Heplisav and expects to have participa - More - ... [Published Mar 17 2010 by SmartBrief]

Entities: Dynavax Technologies Corporation, Hepatitis B Vaccine, HEPLISAV

First Reported Mar 16 2010 - Updated Mar 16 2010 - 5 Documents

Dynavax Anticipates Earlier BLA Submission for HEPLISAV(TM)

DYNAVAX TECHNOLOGIES CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) Three Months Ended Twelve Months Ended December 31, December 31, 2009 2008 2009 2008 - - - - Revenues: Collaboration revenue $ ... [Published Mar 16 2010 by Pharmacy Choice]

Entities: Dynavax Technologies Corporation, HEPLISAV, Operating Expenses

First Reported Mar 16 2010 - Updated Mar 17 2010 - 1 Documents

HEADLINE STOCKS-U.S. small/midcap stocks on the move on March 16

March 16 (Reuters) - Some small and midcap stocks on the move on Tuesday:SEQUENOM INC, $6.18, down 20 pctThe company posted a wider-than-expected fourth-quarter loss, hurt by rising costs and lower average selling price for its systems in the genetic ... [Published Mar 16 2010 by FinanzNachrichten.de]

Entities: Pharmasset Inc, Movado Group Inc, Pericom SemiConductor Corporation

First Reported Mar 16 2010 - Updated Mar 16 2010 - 3 Documents

Food and Drug Administration

Dynavax hopes to submit Heplisav to FDA 6 months early

Dynavax Technologies Corp. hopes to submit its hepatitis B vaccine to the FDA six months earlier than a previous guess.The Berkeley company (NASDAQ: DVAX) has enrolled all 2,000 patients in a large scale Phase III test of the vaccine, and expects to have ... [Published Mar 16 2010 by Biz Journals]

Entities: Dynavax Technologies Corporation, HEPLISAV, Food and Drug Administration

First Reported Mar 16 2010 - Updated Mar 16 2010 - 1 Documents

Merck & Co Inc

Dynavax will get final payment of $4M from Merck for Heplisav

Dynavax Technologies said it will receive a $4 million final payment from Merck & Co. - More - ... [Published Mar 16 2010 by SmartBrief]

Entities: Dynavax Technologies Corporation, HEPLISAV, Merck & Co Inc

First Reported Mar 16 2010 - Updated Mar 16 2010 - 1 Documents

STOCKS NEWS US-Dynavax gets going-concern warning

Stocks on the move Real-time equity news U.S. stock market report 0910 ET 16March2010-Dynavax gets going-concern warning - Dynavax Technologies Corp said ... ... [Published Mar 16 2010 by FinanzNachrichten.de]

Entities: Dynavax Technologies Corporation, Stock Market, United States

First Reported Mar 16 2010 - Updated Mar 16 2010 - 1 Documents

Dynavax (DVAX) Reports Q4 Loss of $0.73; 10-K Includes 'Going Concern' Statement

Dynavax Technologies Corporation (Nasdaq: DVAX) reports Q4 loss of $0.73, which does not compare to the analyst estimate of ($0.23). Revenue for the quarter was $2.9 million, which compares to the estimate of $7.2 million. Dynavax's 10-K also includes ... [Published Mar 16 2010 by Street Insider]

Entities: Dynavax Technologies Corporation, 10-k

First Reported Mar 15 2010 - Updated Mar 16 2010 - 1 Documents

Merck and Dynavax Agree on Payment

Pharmaceutical giant Merck (MRK) has come to an agreement with drug maker Dynavax Technologies (DVAX) to pay $4 million worth of expenses related to a termination of collaboration between the two companies. Merck ended the collaboration.The collaboration ... [Published Mar 15 2010 by FOXBusiness.com]

Entities: Dynavax Technologies Corporation, Interactive Data Corporation, HEPLISAV

First Reported Mar 15 2010 - Updated Mar 15 2010 - 6 Documents

Dynavax, Merck Agree on Final Reimbursements

Dynavax Technologies Corporation announced Monday the successful completion of negotiationsrelating to Merck’s reimbursement obligations underthe former partnership agreements covering the clinical development and commercialization of HEPLISAV, Dynavax’s ... [Published Mar 15 2010 by FDA News]

Entities: Dynavax Technologies Corporation, HEPLISAV, Hepatitis B Vaccine

First Reported Feb 23 2010 - Updated Feb 24 2010 - 3 Documents

Progress for Dynavax Pipeline: Stock Should Perform Well

Dynavax Technologies Corporation (DVAX) announced recently it has selected the molecule DV1179 for clinical development in its endosomal Toll-like Receptor (TLR) inhibitor collaboration with GlaxoSmithKline (GSK). Currently, IND (Investigational New Drug)-Enabling ... [Published Feb 24 2010 by Seeking Alpha]

Entities: Dynavax Technologies Corporation, HEPLISAV, Engerix-B, GlaxoSmithKline plc, Vaccine

First Reported Feb 24 2010 - Updated Feb 24 2010 - 3 Documents

Progress for Dynavax Pipeline: Stock Should Perform Well

Zacks.com submits: Dynavax Technologies Corporation ( DVAX ) announced recently it has selected the molecule DV1179 for clinical development in its endosomal Toll-like Receptor (TLR) inhibitor collaboration with GlaxoSmithKline ( GSK ). Currently, ... [Published Feb 24 2010 by Healthcare Sector and Stocks Analysis from Seek ...]

Entities: Dynavax Technologies Corporation, Receptor, Molecule

First Reported Feb 18 2010 - Updated Feb 19 2010 - 5 Documents

Dynavax, GSK Select Clinical Candidate In Endosomal TLR Inhibitor Program

Dynavax Technologies (Dynavax), in collaboration with GlaxoSmithKline (GSK), has selected a bifunctional TLR inhibitor DV1179 for clinical development in its endosomal Toll-like Receptor (TLR).Dynavax and GSK said that the selected molecule has moved ... [Published Feb 19 2010 by Pharmaceutical Business Review]

Entities: Dynavax Technologies Corporation, Psoriasis, Systemic Lupus Erythematosus, Rheumatoid Arthritis

Quotes

...According to Dino Dina, M D , President and CEO, "The accelerated enrollment and immunization of subjects for the safety and consistency study of HEPLISAV is an important accomplishment that we expect will facilitate the successful conclusion of several ongoing financing discussions. Clearly, this is our highest priority to ensure the success of the program." Dynavax separately reported $36.7 million in unrestricted cash and cash equivalents at December 31, 2009. This compares to $46...

Dynavax (DVAX) Expects Earlier BLA Submission for HEPLISAV(TM) [Street Insider - Mar 16 2010]

...Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO"

BUYINS.NET: Dynavax Technologies (DVAX) Down After BUYINS.NET Report Predicted Weakness After Ear ... [RBC Dain Rauscher - Mar 04 2010]

...sponsored by the President's Council of Advisors on Science and Technology in Washington D CD C According to Dino Dina, M D , President and CEO, "As new pandemic threats such as the H1N1 epidemic of the 2009 flu season emerge, it is becoming increasingly clear that our Universal Flu approach represents an important intervention with the potential to provide broad protection against new strains of the influenza virus. We expect the initial data, including evidence of the biological activity of the vaccine's proprietary components, to be available this year." Dynavax indicated that a GLP toxicity study demonstrated that its Universal FluFlu vaccine candidate is well-tolerated, and clinical material for the...

Dynavax Tech (DVAX) Selects Universal Flu Vaccine; Expects Phase I to Begin Mid-2010 [Street Insider - Feb 25 2010]

More Content

sort by: Date \| Relevance
Dynavax aims to submit application for hepatiti... [SmartBrief - Mar 17 2010]
SmarTrend's Candlestick Scanner Detects Bearish... [TradingMarkets - Mar 17 2010]
SmarTrend's Candlestick Scanner Detects Bearish... [FOXBusiness.com - Mar 17 2010]
SmarTrend's Candlestick Scanner Detects Bearish... [FOXBusiness.com - Mar 17 2010]
Dynavax Anticipates Earlier BLA Submission for ... [Pharmacy Choice - Mar 16 2010]
HEADLINE STOCKS-U.S. small/midcap stocks on the... [FinanzNachrichten.de - Mar 16 2010]
Dynavax hopes to submit Heplisav to FDA 6 month... [Biz Journals - Mar 16 2010]
Dynavax will get final payment of $4M from Merc... [SmartBrief - Mar 16 2010]
UPDATE:Dynavax May Seek FDA OK For Heplisav Ear... [FOXNews.com - Mar 16 2010]
STOCKS NEWS US-Dynavax gets going-concern warning [FinanzNachrichten.de - Mar 16 2010]
Dynavax May Seek FDA Approval For Heplisav Earl... [Nasdaq - Mar 16 2010]
Dynavax Anticipates Earlier BLA Submission for ... [Freshnews.com - Mar 16 2010]
Dynavax Anticipates Earlier BLA Submission for ... [PR inside - Mar 16 2010]
BRIEF-Dynavax Technologies says anticipates ear... [FinanzNachrichten.de - Mar 16 2010]
Dynavax (DVAX) Reports Q4 Loss of $0.73; 10-K I... [Street Insider - Mar 16 2010]
Dynavax (DVAX) Expects Earlier BLA Submission f... [Street Insider - Mar 16 2010]
Merck and Dynavax Agree on Payment [FOXBusiness.com - Mar 15 2010]
Dynavax, Merck Agree on Final Reimbursements [FDA News - Mar 15 2010]
Dynavax To Receive $4 Mln As Final Reimbursemen... [RTTNews.com - Mar 15 2010]
Market Report -- In Play (DVAX) [Briefing.com via MSN Money - Mar 15 2010]
Dynavax Tech. (DVAX) To Receive $4M from Merck ... [Street Insider - Mar 15 2010]
Dynavax and Merck Agree on Final Reimbursements... [PR inside - Mar 15 2010]
Dynavax and Merck Agree on Final Reimbursements [EuroInvestor.co.uk - Mar 15 2010]
Reportlinker Adds Global Chronic Obstructive Pu... [FOXBusiness.com - Mar 12 2010]
Dynavax Technologies Corporation - Pharmaceutic... [PR inside - Mar 10 2010]
Stock Picks For Friday 5 March: OceanFreight, G... [Daily Markets - Mar 05 2010]
BUYINS.NET: Dynavax Technologies (DVAX) Down Af... [RBC Dain Rauscher - Mar 04 2010]
Dynavax, GSK select clinical candidate in the E... [Bio Spectrum Asia - Mar 01 2010]
Stock Picks For Monday 1 March: Ciena, Allied I... [Daily Markets - Feb 28 2010]
BCM researcher part of flu vaccine study [Business Journal of Jacksonville - Feb 26 2010]

Blogs

sort by: Date \| Relevance
Progress for Dynavax Pipeline: Stock Should Per... [Healthcare Sector and Stocks Analysis from Seek ... - Feb 24 2010] Zacks.com submits: Dynavax Technologies Corporation (DVAX) announced recently it has selected the molecule DV1179 for clinical development in its endosomal Toll-like ...
Progress for Dynavax Pipeline: Stock Should Per... [Biotech Sector and Stocks Analysis from Seeking ... - Feb 24 2010] Zacks.com submits: Dynavax Technologies Corporation (DVAX) announced recently it has selected the molecule DV1179 for clinical development in its endosomal Toll-like ...
Good News for Dynavax HBV Vaccine [Healthcare Sector and Stocks Analysis from Seek ... - Dec 13 2009] Zacks.com submits: Dynavax Technologies Corp. (DVAX) announced recently that it has received approval from the European Union to make part of its hepatitis B vaccine ...
Good News for Dynavax HBV Vaccine [Biotech Sector and Stocks Analysis from Seeking ... - Dec 13 2009] Zacks.com submits: Dynavax Technologies Corp. (DVAX) announced recently that it has received approval from the European Union to make part of its hepatitis B vaccine ...
FDA Calendar Updates: Biomoda, Dynavax [Blog entries - Aug 04 2009] Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 286 entries as of 8/4/09. The calendar was originally created by ...